In vivo lymph node <scp>CEST‐Dixon MRI</scp> in breast cancer patients with metastatic lymph node involvement
Manus J. Donahue(Vanderbilt University Medical Center), Rachelle Crescenzi(University of Virginia Medical Center), Ingrid M. Meszoely(Fox Chase Cancer Center), R. Sky Jones(Vanderbilt University Medical Center), Niral Patel(Vanderbilt University Medical Center), Chelsea Lee(Vanderbilt University Medical Center), A. Cooper(Memorial Sloan Kettering Cancer Center), Jill B. De Vis(Southwestern Medical Center), Maria Garza(Vanderbilt University Medical Center), Paula M. C. Donahue(Vanderbilt University)
Cited by 1
Related Papers
Standard of care for lipedema in the United States
|Phlebology The Journal of Venous Disease|2021|255
Theoretical and experimental investigation of the VASO contrast mechanism
|Magnetic Resonance in Medicine|2006|158
Advances in the prevention and treatment of breast cancer-related lymphedema
|Breast Cancer Research and Treatment|2023|147
Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
|Frontiers in Oncology|2020|144
Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma
|Annals of Surgical Oncology|2004|131